<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2017.00104</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Mart&#x000ED;nez-Alem&#x000E1;n</surname> <given-names>Saira R.</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/423711/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Campos-Garc&#x000ED;a</surname> <given-names>Lizbeth</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Palma-Nicolas</surname> <given-names>Jos&#x000E9; P.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Hern&#x000E1;ndez-Bello</surname> <given-names>Romel</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Gonz&#x000E1;lez</surname> <given-names>Gloria M.</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>S&#x000E1;nchez-Gonz&#x000E1;lez</surname> <given-names>Alejandro</given-names></name>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/378228/overview"/>
</contrib>
</contrib-group>
<aff><institution>Departamento de Microbiolog&#x000ED;a, Facultad de Medicina, Universidad Aut&#x000F3;noma de Nuevo Le&#x000F3;n</institution> <country>Monterrey, Mexico</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Silvia Mercedes Uriarte, University of Louisville, USA</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Valerio Iebba, Sapienza University of Rome, Italy; Erika Ildiko Lutter, Oklahoma State University&#x02013;Stillwater, USA</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Alejandro S&#x000E1;nchez-Gonz&#x000E1;lez <email>alejandro.sanchezgn&#x00040;uanl.edu.mx</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>06</day>
<month>04</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>7</volume>
<elocation-id>104</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>09</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>03</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Mart&#x000ED;nez-Alem&#x000E1;n, Campos-Garc&#x000ED;a, Palma-Nicolas, Hern&#x000E1;ndez-Bello, Gonz&#x000E1;lez and S&#x000E1;nchez-Gonz&#x000E1;lez.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Mart&#x000ED;nez-Alem&#x000E1;n, Campos-Garc&#x000ED;a, Palma-Nicolas, Hern&#x000E1;ndez-Bello, Gonz&#x000E1;lez and S&#x000E1;nchez-Gonz&#x000E1;lez</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the gene that codes for the CF trans-membrane conductance regulator. These mutations result in abnormal secretions viscous airways of the lungs, favoring pulmonary infection and inflammation in the middle of neutrophil recruitment. Recently it was described that neutrophils can contribute with disease pathology by extruding large amounts of nuclear material through a mechanism of cell death known as Neutrophil Extracellular Traps (NETs) into the airways of patients with CF. Additionally, NETs production can contribute to airway colonization with bacteria, since they are the microorganisms most frequently found in these patients. In this review, we will discuss the implication of individual or mixed bacterial infections that most often colonize the lung of patients with CF, and the NETs role on the disease.</p>
</abstract>
<kwd-group>
<kwd>neutrophil</kwd>
<kwd>NETs</kwd>
<kwd>cystic fibrosis</kwd>
<kwd>CFTR</kwd>
<kwd><italic>Pseudomonas aeruginosa</italic></kwd>
<kwd><italic>Staphylococcus aureus</italic></kwd>
<kwd><italic>Burkholderia cepacia</italic></kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="68"/>
<page-count count="7"/>
<word-count count="5842"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Cystic Fibrosis (CF) is a lung disease characterized by chronic inflammation of the airways associated with bacterial colonization. Disease occurs by mutations that disrupt the Cystic Fibrosis Transmembrane Regulator (CFTR) gene, a plasma membrane channel that regulates the balance of bicarbonate and chloride secretions across the epithelial layer of the airways. Patients with CF have an elevated presence of thick mucus, DNA and proteins, complexed with bacteria that obstruct airflow due to an inability of the epithelial cilia to beat and mediate mechanical clearance of these structures. More recently, some studies showed that the extracellular DNA levels correlate with neutrophil counts and can be used as a guide of inflammation and lung disease severity (Kirchner et al., <xref ref-type="bibr" rid="B30">1996</xref>; Ratjen et al., <xref ref-type="bibr" rid="B49">2005</xref>).</p>
<p>Neutrophil Extracellular Traps (NETs) release was recently related to the extracellular DNA found in patients with CF in which their presence can exacerbate the disease. The excessive formation of NETs promotes that the mucus in patient&#x00027;s alveoli becomes thicker and sticky, allowing the colonization of bacteria such as <italic>Haemophilus influenzae</italic> and <italic>Staphylococcus aureus</italic>, and significantly <italic>Pseudomonas aeruginosa</italic> (Manzenreiter et al., <xref ref-type="bibr" rid="B36">2012</xref>). Such colonization promotes infiltration of neutrophils that undergo NETosis increasing sputum viscosity and consequently lowering the patient&#x00027;s respiratory capacity. In line with this, a treatment option for patients with CF is the administration of recombinant human DNase to disrupt NETs and so liquefy the sputum and facilitate mucociliary clearance (Papayannopoulos et al., <xref ref-type="bibr" rid="B45">2011</xref>).</p>
</sec>
<sec id="s2">
<title>The neutrophil and its characteristics</title>
<p>Neutrophils are the most abundant white blood cells in circulation and have an important role in the immune response (Amulic et al., <xref ref-type="bibr" rid="B2">2012</xref>). They possess a segmented nucleus and in their cytoplasm, multiple granules and secretory vesicles can be found. These granules have been subdivided into three classes: azurophilic, specific and gelatinase (Kolaczkowska and Kubes, <xref ref-type="bibr" rid="B32">2013</xref>). Neutrophils also produce many peptides and proteins that directly or indirectly kill microbes divided into three types of antimicrobials: cationic peptides (i.e., defensins and cathelicidins); proteolytic enzymes [i.e., lysozyme, myeloperoxidase and neutrophil elastase (NE)] and, metal chelating proteins (i.e., lactoferrin and calprotectin; Borregaard and Cowland, <xref ref-type="bibr" rid="B6">1997</xref>).</p>
<p>When a pathogen is detected, neutrophils leave the blood vessels and are recruited to the site of infection following a chemotactic gradient produced by microbial and endogenous signals (Papayannopoulos and Zychlinsky, <xref ref-type="bibr" rid="B46">2009</xref>; Brinkmann and Zychlinsky, <xref ref-type="bibr" rid="B8">2012</xref>). In the inflammatory site, these cells employ intracellular and extracellular strategies to contain and eliminate the infection (Kolaczkowska and Kubes, <xref ref-type="bibr" rid="B32">2013</xref>). Intracellularly, eliminate pathogens very effectively by phagocytosis and degradation of the cargo in the lizosome, whereas, extracellular mechanims include degranulation where the lytic granules contained in vacuoles are expelled, production of reactive oxygen species that can affect directly the pathogen proteins and DNA and formation of extracellulat traps which can restrict dissemination at the same time that promote pathogen killing (Brinkmann et al., <xref ref-type="bibr" rid="B7">2004</xref>; Papayannopoulos and Zychlinsky, <xref ref-type="bibr" rid="B46">2009</xref>).</p>
</sec>
<sec id="s3">
<title>Neutrophil extracellular traps</title>
<p>NETs formation was first described in 2004 and although plenty of information has arised still many aspects of its regulation are unknown (Brinkmann and Zychlinsky, <xref ref-type="bibr" rid="B8">2012</xref>). To release NETs, the activated neutrophil undergoes dramatic morphological changes mediated by signaling pathways that differ depending on the stimulus. It has been found that chemical inductors such as PMA promote &#x0201C;suicidal NETs&#x0201D; formation in which neutrophils extrude their DNA and die, a process that takes of 1.5&#x02013;2 h to ocurr (Brinkmann and Zychlinsky, <xref ref-type="bibr" rid="B8">2012</xref>; Zawrotniak and Rapala-Kozik, <xref ref-type="bibr" rid="B67">2013</xref>) on the other hand, pathogen inducers promote &#x0201C;vital NETs&#x0201D; formation in matters of minutes (0.5&#x02013;1 h) in which the cells extrude their DNA but still can migrate and kill pathogens by phagocytosis (Yipp and Kubes, <xref ref-type="bibr" rid="B65">2016</xref>).</p>
<p>In the initial steps of NETs formation, minutes after activation, the neutrophil flattens and adheres firmly to a substrate, such adhesion is mediated by integrin receptors (Neeli et al., <xref ref-type="bibr" rid="B41">2008</xref>). When &#x0201C;suicidal NETs&#x0201D; are induced neutrophil binding to its substrate promotes the activation of the NADPH oxidase complex, when is assembled in the fagosomal cell membrane and reduces the molecular oxygen superoxide anion by electron transfer. Superoxide dismutase (SOD) converts superoxide anion into hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), which acts in turn as a substrate for the enzyme myeloperoxidase (MPO), and also reacts with H<sub>2</sub>O<sub>2</sub> to generate hypochlorous acid (Brinkmann and Zychlinsky, <xref ref-type="bibr" rid="B8">2012</xref>). In contrast, ROS formation is not escential in &#x0201C;vital NETs&#x0201D; since in this a NADPH oxidase independent mechanism has been described to some pathogens (Rochael et al., <xref ref-type="bibr" rid="B50">2015</xref>; Yipp and Kubes, <xref ref-type="bibr" rid="B65">2016</xref>). In a subsequent step, the nucleus loses its lobed shape and the chromatin is decondensed by action of NE and MPO enzymes, that migrate to the nucleus where they exert their proteolytic function on histones (Fuchs et al., <xref ref-type="bibr" rid="B19">2007</xref>; Papayannopoulos et al., <xref ref-type="bibr" rid="B44">2010</xref>). Concomitantly, chromatin decondensation can be increased due to epigenetic mechanisms on histones, as it was found that histones H3 and H4 can be modified by a reaction catalyzed by arginine peptidyl deaminase 4 (PAD4) that converts arginine residues to citrulline (Wang et al., <xref ref-type="bibr" rid="B62">2009</xref>; Leshner et al., <xref ref-type="bibr" rid="B33">2012</xref>). Later, the nuclear envelope disintegrates, nucleoplasm and cytoplasm are mixed forming a homogeneous mass, and finally, rupture of the cell membrane promotes that the cellular contents are expelled into the extracellular space (Fuchs et al., <xref ref-type="bibr" rid="B19">2007</xref>; Brinkmann and Zychlinsky, <xref ref-type="bibr" rid="B8">2012</xref>).</p>
</sec>
<sec id="s4">
<title>The function of NETs</title>
<p>NETs likely evolved to restrict infections due to its ability to entrap, prevent the spread and exterminate microorganisms (Brinkmann and Zychlinsky, <xref ref-type="bibr" rid="B8">2012</xref>), as they can catch almost all types of pathogens as its presence has been demonstrated in response against gram-positive and gram-negative bacterial infections, yeasts, viruses and protozoan parasites (Lu et al., <xref ref-type="bibr" rid="B35">2012</xref>). Capture within the fibers of DNA prevents propagation of microorganisms on the body and facilitates a higher concentration of antimicrobial factors at the site of infection (Brinkmann et al., <xref ref-type="bibr" rid="B7">2004</xref>). This capture occurs through charge interactions between cell surface components of the pathogen and NETs and its antimicrobial functions are exerted by the granular proteins, primarily by NE, histone and MPO, but also by the action of calgranulin, proteinase 3, lactoferrin, calprotectin, and antimicrobial peptides (AMP) such as defensins or cathelicidin LL-37 (Urban et al., <xref ref-type="bibr" rid="B58">2009</xref>).</p>
<p>In addition to the antimicrobial function of NETs, its ineffective elimination or excessive presence can cause pathological effects. NETs formation has been observed during chronic inflammatory diseases (atherosclerosis), autoimmune diseases such as systemic lupus erythematosus (SLE), in various forms of vasculitis, thrombosis, as well as pulmonary diseases such as CF (Kolaczkowska and Kubes, <xref ref-type="bibr" rid="B32">2013</xref>).</p>
</sec>
<sec id="s5">
<title>Cystic fibrosis and its relationship with NETs</title>
<p>CF is a disease produced by mutations that disrupt the CFTR gene (Table <xref ref-type="table" rid="T1">1</xref>); the effect of these mutations is the production of abnormally viscous secretions in the airways of the lungs causing obstructions, inflammation and tissue destruction (Cutting, <xref ref-type="bibr" rid="B13">2015</xref>). On the other hand, an important role on the immunopathology of the disease has been given to immune cells. Particularly, considerable participation of neutrophils has been proposed, as these cells have an increased influx to the lungs of the patients in response to bacterial colonization (Gray et al., <xref ref-type="bibr" rid="B23">2015</xref>), but present a reduced ability to remove microbes due to an ineffective respiratory burst (Painter et al., <xref ref-type="bibr" rid="B43">2008</xref>) and induce an exacerbated local tissue damage because of uncontrolled degranulation (Rogan et al., <xref ref-type="bibr" rid="B51">2004</xref>; Sagel et al., <xref ref-type="bibr" rid="B54">2004</xref>; Bergsson et al., <xref ref-type="bibr" rid="B4">2009</xref>). Recently, NETs formation has drawn attention as it has been found that once free DNA is present in high quantity of in the sputum, patients present diminished lung function when compared with patients that have mild disease, indicating that the airway obstruction is due to the accumulation of NETs-DNA (Papayannopoulos et al., <xref ref-type="bibr" rid="B45">2011</xref>; Dubois et al., <xref ref-type="bibr" rid="B14">2012</xref>; Dwyer et al., <xref ref-type="bibr" rid="B15">2014</xref>; Marcos et al., <xref ref-type="bibr" rid="B37">2015</xref>). Also, it has been reported that components of NETs (i.e., mieloperoxidase, neutrophil elastase and histones) can induce destruction of epithelial, endothelial and connective tissue worsening the lung pathology (Klebanoff et al., <xref ref-type="bibr" rid="B31">1993</xref>; Manzenreiter et al., <xref ref-type="bibr" rid="B36">2012</xref>; Saffarzadeh et al., <xref ref-type="bibr" rid="B53">2012</xref>). The importance of NETs in this disease is underscored by observations describing that elimination of free DNA from patient&#x00027;s airways constitute an important treatment option for combating CF since administration of recombinant human DNase, leads to a significate improvement on health (Rahman and Gadjeva, <xref ref-type="bibr" rid="B48">2014</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p><bold>Classes of CFTR mutations that cause cystic fibrosis</bold>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Class</bold></th>
<th valign="top" align="left"><bold>Defect</bold></th>
<th valign="top" align="left"><bold>Example</bold></th>
<th valign="top" align="left"><bold>References</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">I</td>
<td valign="top" align="left">About half of the CFTR mutations are expected to prevent proper synthesis of full-length, normal CFTR polypeptide because of nonsense, frameshift, or aberrant splicing of mRNA.</td>
<td valign="top" align="left">G542X</td>
<td valign="top" align="left">Rowe et al., <xref ref-type="bibr" rid="B52">2005</xref></td>
</tr>
<tr>
<td valign="top" align="left">II</td>
<td valign="top" align="left">The defective protein retains substantial chloride-channel function in cell-free lipid membranes. When synthesized by the normal cellular machinery, however, the protein is rapidly recognized as misfolded and is degraded shortly after synthesis, before it can reach its crucial site of action at the cell surface.</td>
<td valign="top" align="left">&#x00394;F508<break/> N1303K<break/> G85E<break/> G91R</td>
<td valign="top" align="left">O&#x00027;Sullivan and Freedman, <xref ref-type="bibr" rid="B42">2009</xref></td>
</tr>
<tr>
<td valign="top" align="left">III</td>
<td valign="top" align="left">It encodes properly processed, full-length CFTR protein that lacks normal ion-channel activity</td>
<td valign="top" align="left">G551D<break/> G551S<break/> G1244E<break/> G1255P<break/> G1349D</td>
<td valign="top" align="left">Rowe et al., <xref ref-type="bibr" rid="B52">2005</xref></td>
</tr>
<tr>
<td valign="top" align="left">IV</td>
<td valign="top" align="left">This mutation exhibits only partial CFTR ion-channel activity, a feature that probably explains a less severe pulmonary phenotype.</td>
<td valign="top" align="left">A455E<break/> R117H<break/> R334W<break/> R347P</td>
<td valign="top" align="left">Gan et al., <xref ref-type="bibr" rid="B20">1995</xref></td>
</tr>
<tr>
<td valign="top" align="left">V</td>
<td valign="top" align="left">It includes promoter mutations that reduce transcription, nucleotide alterations that promote alternative splicing of the CFTR transcript, and amino acid substitutions that cause inefficient protein maturation.</td>
<td valign="top" align="left">P574H<break/> A455E</td>
<td valign="top" align="left">Welsh and Smith, <xref ref-type="bibr" rid="B63">1993</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s6">
<title>NETs formation by microorganisms of cystic fibrosis</title>
<p>In the lungs, the first point of contact for contaminants and microorganisms is the respiratory tract (Cullen and McClean, <xref ref-type="bibr" rid="B12">2015</xref>). Sophisticated host defense mechanisms in the mucosa of the lungs, especially in healthy individuals, as well as the presence of cilia and mucus epithelial surface prevent infections trapping and removing particles and microorganisms of the healthy lung, even though the microorganisms are constantly inhaled (Eisele and Anderson, <xref ref-type="bibr" rid="B16">2011</xref>). CF is characterized by airway inflammation, increased viscous mucus production and reduced mucociliary clearance, favoring chronic infections that contribute to a rapid decline in lung function and health (Cullen and McClean, <xref ref-type="bibr" rid="B12">2015</xref>).</p>
<p>The alterations in the lung surface provides a suitable environment for the growth of various pathogens, being the most represented bacteria and fungi; among which, <italic>Pseudomonas aeruginosa</italic> constitutes one of the most prevalent pathogens that colonizes the lungs of CF patients (Cullen and McClean, <xref ref-type="bibr" rid="B12">2015</xref>). Elimination of this bacteria results very difficult for the immune system since it is known that when infects the patient&#x00027;s lungs, this pathogen can migrate to areas with low oxygen concentrations where only few immune cells can exert its function (Young et al., <xref ref-type="bibr" rid="B66">2011</xref>). Among these cells, the neutrophils constitute the primary defense line but <italic>P. aeruginosa</italic> has developed strategies to evade their destruction, as it has been shown that biofilm formation promotes excessive production of alginate that allows bacterial evasion to neutrophil phagocytosis and degranulation (Mulcahy et al., <xref ref-type="bibr" rid="B40">2008</xref>). Additionally, <italic>P. aeruginosa</italic> has obtained diverse mechanisms to evade the effects of NETs, among these it is know that they can counteract the capacity of these structures to chelate divalent metal cations by overexpression of genes controlled by the two component systems PhoPQ and PmrAB that sense Mg<sup>2&#x0002B;</sup> limitation and at the same time encodes mechanisms to effectively obtain the ion (Mulcahy et al., <xref ref-type="bibr" rid="B40">2008</xref>; Johnson et al., <xref ref-type="bibr" rid="B28">2012</xref>, <xref ref-type="bibr" rid="B27">2013</xref>). Additionally, the bacteria is capable of regulating genes that allow them to tolerate the toxicity caused by the extracellular DNA (Halverson et al., <xref ref-type="bibr" rid="B24">2015</xref>).</p>
<p>Respiratory tract colonization of CF patients by <italic>Staphylococcus aureus</italic> has drawn increasing attention, as it has been found that they suffer a more aggressive form of the disease. Possible explanations to this are not well understood, but the effect has been attributed to the high production of bacterial toxins that can induce strong damage to the patient&#x00027;s airways and to the resistance that this bacterium has against the immune mechanisms which include phagocytosis and degranulation evasion through production of capsule (Menestrina et al., <xref ref-type="bibr" rid="B39">2003</xref>; Voyich et al., <xref ref-type="bibr" rid="B60">2005</xref>). The role of NETosis in the response against <italic>S. aureus</italic> in CF is still not completely known but now is suggested that these structures can be more harmful that beneficial for patient&#x00027;s health. It has been reported that toxins produced by this bacterium can induce different types of cell death depending on the concentration including NETs (Genestier et al., <xref ref-type="bibr" rid="B21">2005</xref>), but their antimicrobial effect could be limited due to a production a DNAse by the bacteria (Pilsczek et al., <xref ref-type="bibr" rid="B47">2010</xref>) and moreover could contribute to tissue damage by increasing the local concentration of cytotoxic molecules. Additionally, experiments <italic>in vitro</italic> have shown that neutrophils infected with <italic>S. aureus</italic> can induce NETs with a faster kinetic resembling &#x0201C;vital NETs&#x0201D; formation (Pilsczek et al., <xref ref-type="bibr" rid="B47">2010</xref>), and other group demonstrated that these structures are modified in a way to become cytotoxic for macrophages allowing the establishment of chronic infections and increased tissue damage (Thammavongsa et al., <xref ref-type="bibr" rid="B57">2013</xref>).</p>
<p>Other groups of bacteria that have been found colonizing the respiratory tract of CF patients include <italic>Haemophilus influenza, Stenotrophomonas maltophilia, Achromobacter xyloxidans</italic>, genus <italic>Pandoraea</italic> and <italic>Streptococci</italic> (LiPuma, <xref ref-type="bibr" rid="B34">2010</xref>; Callaghan and McClean, <xref ref-type="bibr" rid="B10">2012</xref>). However, it has not been reported the formation of NETs by any of these bacteria in CF and its role on the disease still remains to be explored. A growing concern among clinicians is the observation of adult patient&#x00027;s lungs colonization with <italic>Burkholderia cepacia</italic> since it has been related to decreased respiratory function and worsening of the disease, the mechanisms behind this are not understood although it has been proposed a possible association with previously colonizing bacteria (<italic>Pseudomonas aeruginosa</italic> and/or <italic>Staphylococcus aureus</italic>) to form mixed clusters of pathogens.</p>
<p>NETs and bacterial biofilms can be found in high amounts in CF patient&#x00027;s lung, the possible relationship of these structures induced by bacteria colonizing the alveoli of CF patients is an interesting aspect to study, as it could be possible that the pathogen promotes biofilm and NET formation to use these structures as a niche to stablish the infection and persist at the cost of a detriment in patient&#x00027;s health. The idea results attractive as some groups have shown that in otitis media and supragingival infections some surface bacterial proteins determinants for biofilm formation can also attract neutrophils to the site of infection to induce NETs and at the same time contribute to avoid their elimination by the induced traps and phagocytic killing by other incoming cells (Juneau et al., <xref ref-type="bibr" rid="B29">2011</xref>; Hirschfeld et al., <xref ref-type="bibr" rid="B25">2015</xref>).</p>
<p>Figure <xref ref-type="fig" rid="F1">1</xref> summarizes the information about the effect of mixed or single infections on the CF. <italic>P. aeruginosa</italic> is considered the main bacterium that affects people with CF, causing chronic lung infections, which leads to high rates of morbidity and mortality, and once the bacteria is established, it is difficult to eradicate it (Winstanley et al., <xref ref-type="bibr" rid="B64">2016</xref>). On the other hand, patients colonized in a chronic manner with <italic>B. cepacia</italic> present a worse prognosis of the disease, as the use of antibiotics becomes more frequent they also have a greater deterioration of lung function and the rate of mortality is higher compared to that patients colonized by only <italic>P. aeruginosa</italic> (Gilligan, <xref ref-type="bibr" rid="B22">2014</xref>; Folescu et al., <xref ref-type="bibr" rid="B18">2015</xref>). It has been reported that <italic>B. cepacia</italic> and <italic>P. aeruginosa</italic> can form mixed biofilms in the lungs of people with CF, since, <italic>P. aeruginosa</italic> through its extracellular products can increase the attachment of <italic>B. cepacia</italic> by modifying the lung epithelial cells on its surface; however, the same does not occur in patients previously colonized with <italic>B. cepacia</italic> (Saiman et al., <xref ref-type="bibr" rid="B55">1990</xref>). Coinfection between the two bacteria results in a rapid decline in lung function and a high mortality rate (Folescu et al., <xref ref-type="bibr" rid="B18">2015</xref>). In CF the simple colonization by <italic>S. aureus</italic> is generally considered of better prognosis than those colonized with <italic>P. aeruginosa</italic>; but in some cases, the presence of small-colony variants (SCV) of <italic>S. aureus</italic> is associated with the most advanced lung disease in CF, and the phenotype of this bacterium in a coinfection with <italic>P. aeruginosa</italic> causes disease worsening (Besier et al., <xref ref-type="bibr" rid="B5">2007</xref>; Hubert et al., <xref ref-type="bibr" rid="B26">2013</xref>). In addition, some groups have found that host-pathogen interactions can affect the environment favoring pulmonary disease (Filkins and O&#x00027;Toole, <xref ref-type="bibr" rid="B17">2015</xref>) and that high levels of inflammation as well as an increase in the accumulation of calprotectin possibly related to NET formation promotes coinfection between <italic>P. aeruginosa</italic> and <italic>S. aureus</italic> (Wakeman et al., <xref ref-type="bibr" rid="B61">2016</xref>). Additionally, reports have been published showing that <italic>P. aeruginosa, S. aureus</italic>, and <italic>B. cepacia</italic> can cause mixed infections in the respiratory tract of patients with CF; together, lead to pulmonary exacerbations, decreased pulmonary function and destruction of the lung, so the mortality rate is higher compared to simple infections or mixed infections with two different bacteria (Zemanick et al., <xref ref-type="bibr" rid="B68">2011</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>NET formation in the lung surface of cystic fibrosis patients</bold>. Implications on disease prognosis (text box) in bacterial single infections (middle panel) and coinfections (lower panel) are shown. NET formation can constitute a scaffold for the establishment of simple infections or coinfections that can directly influence the elimination of pathogens that have direct repercussions on patient&#x00027;s health. Upper panel, within single infections, <italic>P. aeruginosa</italic> is the main bacterium that colonizes the lungs of patients with cystic fibrosis, and is associated with decreased microbiome as compared to healthy individuals. Patients colonized with <italic>B. cepacia</italic> are at higher risk of developing septicemia by decreasing their life expectancy. On the other hand, <italic>S. aureus</italic> is less aggressive compared to <italic>P. aeruginosa</italic> and <italic>B. cepacia</italic>, despite this, it can decrease lung function and increase the mortality rate. Bottom panel, mixed infections caused by <italic>P. aeruginosa</italic> and <italic>B. cepacia</italic> may become the most aggressive, due to a rapid loss of lung function, increasing the risk of pulmonary exacerbation and mortality. Coinfections between <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>, have a very antagonistic interaction in which they compete for their establishment by decreasing the rate of acquisition and the rate of loss of another, such battle promote increased lung damage and rapid worsening of patient&#x00027;s health. On the other hand, coinfections between <italic>P. aeruginosa, S. aureus</italic>, and <italic>B. cepacia</italic> causes progressive lung disease and decreased lung function severely compromising patients&#x00027; health.</p></caption>
<graphic xlink:href="fcimb-07-00104-g0001.tif"/>
</fig>
<p>CF investigations have focused on the role that bacteria on the pathogenesis of the disease, although very often other pathogens can be observed and isolated form CF patient&#x00027;s lungs. Of these, filamentous fungi <italic>Aspergillus fumigatus</italic> is the most commonly isolated (Armstead et al., <xref ref-type="bibr" rid="B3">2014</xref>) and even thou detailed studies regarding its participation on CF and NET formation are scarce there are some data that could suggest an active role in the disease. <italic>In vitro</italic> it has been reported formation of high amounts of NETs against <italic>A. fumigatus</italic> hyphae compared to conidia by human neutrophils. Interestingly, NETs are unable to kill and eliminate <italic>A. fumigatus</italic> infection, but can reduce the growth of this fungus by trapping it into webs preventing further growth and confine the infection (McCormick et al., <xref ref-type="bibr" rid="B38">2010</xref>). Additionally, other groups have related the reduction of NET formation to the presence of hydrophobin RodA, which is the major component of resting conidia surface although the precise mechanism behind this still has to be elucidated (Aimanianda et al., <xref ref-type="bibr" rid="B1">2009</xref>; Bruns et al., <xref ref-type="bibr" rid="B9">2010</xref>). Another fungi species that have been also isolated from CF patients are the hyaline fungi <italic>Scedosporium apiospermum</italic> (<italic>Pseudollescheria boydii</italic>) and black yeast <italic>Exophiala dermatitidis</italic> (Chotirmall and McElvaney, <xref ref-type="bibr" rid="B11">2014</xref>) but NET formation and its importance in the disease has not been reported yet.</p>
<p><italic>Candida albicans</italic> can also be isolated from the respiratory tract from CF patients but less frequently than other species and tend to colonize the mucoid membranes of the alimentary tract causing inflammation in the oral cavity (LiPuma, <xref ref-type="bibr" rid="B34">2010</xref>; Chotirmall and McElvaney, <xref ref-type="bibr" rid="B11">2014</xref>). Studies <italic>in vitro</italic> have shown that <italic>C. albicans</italic> promotes NET formation in human neutrophils and this structures can entrap and kill both the hyphae and yeast forms, (Urban et al., <xref ref-type="bibr" rid="B59">2006</xref>, <xref ref-type="bibr" rid="B58">2009</xref>). NET killing was mediated by neutrophil calprotectin that chelates essential ions such as Zn<sup>2&#x0002B;</sup> and Mn<sup>2&#x0002B;</sup> (Sohnle et al., <xref ref-type="bibr" rid="B56">1996</xref>) essential for fungal growth. The last can offer a possible explanation about why this opportunistic fungus is not often found in CF patients but still more studies are needed to truly understand the mechanisms behind this.</p>
</sec>
<sec id="s7">
<title>Concluding remarks</title>
<p>To date, the NETs remain a mystery and its mechanisms of formation has not been completely deciphered. Clearly, it is important for the clearance and containment of a variety of microorganisms, but equally are involved in the development immunopathology of CF, where exacerbate the disease. It is important to fully elucidate the participation of NETs in CF and its interplay with the pathogens colonizing the patient&#x00027;s lungs for in the future develop proper strategies to control the disease.</p>
</sec>
<sec id="s8">
<title>Author contributions</title>
<p>Wrote the manuscript: SM and AS. Helped with manuscript preparation: LC, JP, and RH. Helped with commentaries and writing of the manuscript: GG.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This work was supported by the Autonomous University of Nuevo Le&#x000F3;n in M&#x000E9;xico through its Support Program for Scientific and Technological Research (PAICYT) 2015. We thank to the Ethics and Research committee of the Medicine Faculty and University Hospital &#x0201C;Dr. Jos&#x000E9; Eleuterio Gonz&#x000E1;lez&#x0201D; of the UANL for their help and support for the publication of this work.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack><p>We thank the Microbiology Department members at the Medicine Faculty of the Autonomous University of Nuevo Le&#x000F3;n in M&#x000E9;xico for their support and advice during the preparation of this review.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aimanianda</surname> <given-names>V.</given-names></name> <name><surname>Bayry</surname> <given-names>J.</given-names></name> <name><surname>Bozza</surname> <given-names>S.</given-names></name> <name><surname>Kniemeyer</surname> <given-names>O.</given-names></name> <name><surname>Perruccio</surname> <given-names>K.</given-names></name> <name><surname>Elluru</surname> <given-names>S. R.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Surface hydrophobin prevents immune recognition of airborne fungal spores</article-title>. <source>Nature</source> <volume>460</volume>, <fpage>1117</fpage>&#x02013;<lpage>1121</lpage>. <pub-id pub-id-type="doi">10.1038/nature08264</pub-id><pub-id pub-id-type="pmid">19713928</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amulic</surname> <given-names>B.</given-names></name> <name><surname>Cazalet</surname> <given-names>C.</given-names></name> <name><surname>Hayes</surname> <given-names>G. L.</given-names></name> <name><surname>Metzler</surname> <given-names>K. D.</given-names></name> <name><surname>Zychlinsky</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Neutrophil function: from mechanisms to disease</article-title>. <source>Annu. Rev. Immunol.</source> <volume>30</volume>, <fpage>459</fpage>&#x02013;<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074942</pub-id><pub-id pub-id-type="pmid">22224774</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Armstead</surname> <given-names>J.</given-names></name> <name><surname>Morris</surname> <given-names>J.</given-names></name> <name><surname>Denning</surname> <given-names>D. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis</article-title>. <source>PLoS ONE</source> <volume>9</volume>:<fpage>e98502</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0098502</pub-id><pub-id pub-id-type="pmid">24914809</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergsson</surname> <given-names>G.</given-names></name> <name><surname>Reeves</surname> <given-names>E. P.</given-names></name> <name><surname>McNally</surname> <given-names>P.</given-names></name> <name><surname>Chotirmall</surname> <given-names>S. H.</given-names></name> <name><surname>Greene</surname> <given-names>C. M.</given-names></name> <name><surname>Greally</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline</article-title>. <source>J. Immunol.</source> <volume>183</volume>, <fpage>543</fpage>&#x02013;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0803959</pub-id><pub-id pub-id-type="pmid">19542465</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Besier</surname> <given-names>S.</given-names></name> <name><surname>Smaczny</surname> <given-names>C.</given-names></name> <name><surname>Von Mallinckrodt</surname> <given-names>C.</given-names></name> <name><surname>Krahl</surname> <given-names>A.</given-names></name> <name><surname>Ackermann</surname> <given-names>H.</given-names></name> <name><surname>Brade</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Prevalence and clinical significance of <italic>Staphylococcus aureus</italic> small-colony variants in cystic fibrosis lung disease</article-title>. <source>J. Clin. Microbiol.</source> <volume>45</volume>, <fpage>168</fpage>&#x02013;<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.01510-06</pub-id><pub-id pub-id-type="pmid">17108072</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borregaard</surname> <given-names>N.</given-names></name> <name><surname>Cowland</surname> <given-names>J. B.</given-names></name></person-group> (<year>1997</year>). <article-title>Granules of the human neutrophilic polymorphonuclear leukocyte</article-title>. <source>Blood</source> <volume>89</volume>, <fpage>3503</fpage>&#x02013;<lpage>3521</lpage>. <pub-id pub-id-type="pmid">9160655</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brinkmann</surname> <given-names>V.</given-names></name> <name><surname>Reichard</surname> <given-names>U.</given-names></name> <name><surname>Goosmann</surname> <given-names>C.</given-names></name> <name><surname>Fauler</surname> <given-names>B.</given-names></name> <name><surname>Uhlemann</surname> <given-names>Y.</given-names></name> <name><surname>Weiss</surname> <given-names>D. S.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Neutrophil extracellular traps kill bacteria</article-title>. <source>Science</source> <volume>303</volume>, <fpage>1532</fpage>&#x02013;<lpage>1535</lpage>. <pub-id pub-id-type="doi">10.1126/science.1092385</pub-id><pub-id pub-id-type="pmid">15001782</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brinkmann</surname> <given-names>V.</given-names></name> <name><surname>Zychlinsky</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Neutrophil extracellular traps: is immunity the second function of chromatin?</article-title> <source>J. Cell Biol.</source> <volume>198</volume>, <fpage>773</fpage>&#x02013;<lpage>783</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201203170</pub-id><pub-id pub-id-type="pmid">22945932</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruns</surname> <given-names>S.</given-names></name> <name><surname>Kniemeyer</surname> <given-names>O.</given-names></name> <name><surname>Hasenberg</surname> <given-names>M.</given-names></name> <name><surname>Aimanianda</surname> <given-names>V.</given-names></name> <name><surname>Nietzsche</surname> <given-names>S.</given-names></name> <name><surname>Thywissen</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Production of extracellular traps against Aspergillus fumigatus <italic>in vitro</italic> and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA</article-title>. <source>PLoS Pathog.</source> <volume>6</volume>:<fpage>e1000873</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000873</pub-id><pub-id pub-id-type="pmid">20442864</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Callaghan</surname> <given-names>M.</given-names></name> <name><surname>McClean</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Bacterial host interactions in cystic fibrosis</article-title>. <source>Curr. Opin. Microbiol.</source> <volume>15</volume>, <fpage>71</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2011.11.001</pub-id><pub-id pub-id-type="pmid">22137884</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chotirmall</surname> <given-names>S. H.</given-names></name> <name><surname>McElvaney</surname> <given-names>N. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Fungi in the cystic fibrosis lung: bystanders or pathogens?</article-title> <source>Int. J. Biochem. Cell Biol.</source> <volume>52</volume>, <fpage>161</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2014.03.001</pub-id><pub-id pub-id-type="pmid">24625547</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname> <given-names>L.</given-names></name> <name><surname>McClean</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Bacterial adaptation during chronic respiratory infections</article-title>. <source>Pathogens</source> <volume>4</volume>, <fpage>66</fpage>&#x02013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.3390/pathogens4010066</pub-id><pub-id pub-id-type="pmid">25738646</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutting</surname> <given-names>G. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Cystic fibrosis genetics: from molecular understanding to clinical application</article-title>. <source>HHS Public Access</source> <volume>16</volume>, <fpage>45</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/nrg3849</pub-id><pub-id pub-id-type="pmid">25404111</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubois</surname> <given-names>A. V.</given-names></name> <name><surname>Gauthier</surname> <given-names>A.</given-names></name> <name><surname>Br&#x000E9;a</surname> <given-names>D.</given-names></name> <name><surname>Varaigne</surname> <given-names>F.</given-names></name> <name><surname>Diot</surname> <given-names>P.</given-names></name> <name><surname>Gauthier</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>47</volume>, <fpage>80</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1165/rcmb.2011-0380OC</pub-id><pub-id pub-id-type="pmid">22343221</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dwyer</surname> <given-names>M.</given-names></name> <name><surname>Shan</surname> <given-names>Q.</given-names></name> <name><surname>D&#x00027;Ortona</surname> <given-names>S.</given-names></name> <name><surname>Maurer</surname> <given-names>R.</given-names></name> <name><surname>Mitchell</surname> <given-names>R.</given-names></name> <name><surname>Olesen</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Cystic fibrosis sputum DNA has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor</article-title>. <source>J. Innate Immun.</source> <volume>6</volume>, <fpage>765</fpage>&#x02013;<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1159/000363242</pub-id><pub-id pub-id-type="pmid">24862346</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eisele</surname> <given-names>N. A.</given-names></name> <name><surname>Anderson</surname> <given-names>D. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Host defense and the airway epithelium: frontline responses that protect against bacterial invasion and pneumonia</article-title>. <source>J. Pathog.</source> <volume>2011</volume>:<fpage>249802</fpage>. <pub-id pub-id-type="doi">10.4061/2011/249802</pub-id><pub-id pub-id-type="pmid">22567325</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Filkins</surname> <given-names>L. M.</given-names></name> <name><surname>O&#x00027;Toole</surname> <given-names>G. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat</article-title>. <source>PLoS Pathog.</source> <volume>11</volume>:<fpage>e1005258</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005258</pub-id><pub-id pub-id-type="pmid">26719892</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Folescu</surname> <given-names>T. W.</given-names></name> <name><surname>da Costa</surname> <given-names>C. H.</given-names></name> <name><surname>Cohen</surname> <given-names>R. W. F.</given-names></name> <name><surname>da Concei&#x000E7;&#x000E3;o Neto</surname> <given-names>O. C.</given-names></name> <name><surname>Albano</surname> <given-names>R. M.</given-names></name> <name><surname>Marques</surname> <given-names>E. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Burkholderia cepacia complex: clinical course in cystic fibrosis patients</article-title>. <source>BMC Pulm. Med.</source> <volume>15</volume>:<fpage>158</fpage>. <pub-id pub-id-type="doi">10.1186/s12890-015-0148-2</pub-id><pub-id pub-id-type="pmid">26642758</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname> <given-names>T. A.</given-names></name> <name><surname>Abed</surname> <given-names>U.</given-names></name> <name><surname>Goosmann</surname> <given-names>C.</given-names></name> <name><surname>Hurwitz</surname> <given-names>R.</given-names></name> <name><surname>Schulze</surname> <given-names>I.</given-names></name> <name><surname>Wahn</surname> <given-names>V.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Novel cell death program leads to neutrophil extracellular traps</article-title>. <source>J. Cell Biol.</source> <volume>176</volume>, <fpage>231</fpage>&#x02013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200606027</pub-id><pub-id pub-id-type="pmid">17210947</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname> <given-names>K. H.</given-names></name> <name><surname>Veeze</surname> <given-names>H. J.</given-names></name> <name><surname>van den Ouweland</surname> <given-names>A. M.</given-names></name> <name><surname>Halley</surname> <given-names>D. J.</given-names></name> <name><surname>Scheffer</surname> <given-names>H.</given-names></name> <name><surname>van der Hout</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>1995</year>). <article-title>A cystic fibrosis mutation associated with mild lung disease</article-title>. <source>N. Engl. J. Med.</source> <volume>333</volume>, <fpage>95</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="pmid">7539891</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Genestier</surname> <given-names>A. L.</given-names></name> <name><surname>Michallet</surname> <given-names>M. C.</given-names></name> <name><surname>Pr&#x000E9;vost</surname> <given-names>G.</given-names></name> <name><surname>Bellot</surname> <given-names>G.</given-names></name> <name><surname>Chalabreysse</surname> <given-names>L.</given-names></name> <name><surname>Peyrol</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title><italic>Staphylococcus aureus</italic> Panton-Valentine leucocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils</article-title>. <source>J. Clin. Invest.</source> <volume>115</volume>, <fpage>3117</fpage>&#x02013;<lpage>3127</lpage>. <pub-id pub-id-type="doi">10.1172/JCI22684</pub-id><pub-id pub-id-type="pmid">16276417</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilligan</surname> <given-names>P. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Infections in patients with cystic fibrosis: diagnostic microbiology update</article-title>. <source>Clin. Lab. Med.</source> <volume>34</volume>, <fpage>197</fpage>&#x02013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.cll.2014.02.001</pub-id><pub-id pub-id-type="pmid">24856524</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname> <given-names>R.</given-names></name> <name><surname>McCullagh</surname> <given-names>B.</given-names></name> <name><surname>McCray</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>NETs and CF lung disease: current status and future prospects</article-title>. <source>Antibiotics</source> <volume>4</volume>, <fpage>62</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.3390/antibiotics4010062</pub-id><pub-id pub-id-type="pmid">27025615</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halverson</surname> <given-names>T. W. R.</given-names></name> <name><surname>Wilton</surname> <given-names>M.</given-names></name> <name><surname>Poon</surname> <given-names>K. K. H.</given-names></name> <name><surname>Petri</surname> <given-names>B.</given-names></name> <name><surname>Lewenza</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>DNA is an antimicrobial component of neutrophil extracellular traps</article-title>. <source>PLoS Pathog.</source> <volume>11</volume>:<fpage>e1004593</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1004593</pub-id><pub-id pub-id-type="pmid">25590621</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirschfeld</surname> <given-names>J.</given-names></name> <name><surname>Dommisch</surname> <given-names>H.</given-names></name> <name><surname>Skora</surname> <given-names>P.</given-names></name> <name><surname>Horvath</surname> <given-names>G.</given-names></name> <name><surname>Latz</surname> <given-names>E.</given-names></name> <name><surname>Hoerauf</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Neutrophil extracellular trap formation in supragingival biofilms</article-title>. <source>Int. J. Med. Microbiol.</source> <volume>305</volume>, <fpage>453</fpage>&#x02013;<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2015.04.002</pub-id><pub-id pub-id-type="pmid">25959370</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hubert</surname> <given-names>D.</given-names></name> <name><surname>R&#x000E9;glier-Poupet</surname> <given-names>H.</given-names></name> <name><surname>Sermet-Gaudelus</surname> <given-names>I.</given-names></name> <name><surname>Ferroni</surname> <given-names>A.</given-names></name> <name><surname>Le Bourgeois</surname> <given-names>M.</given-names></name> <name><surname>Burgel</surname> <given-names>P. R.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Association between <italic>Staphylococcus aureus</italic> alone or combined with <italic>Pseudomonas aeruginosa</italic> and the clinical condition of patients with cystic fibrosis</article-title>. <source>J. Cystic Fibros.</source> <volume>12</volume>, <fpage>497</fpage>&#x02013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcf.2012.12.003</pub-id><pub-id pub-id-type="pmid">23291443</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>L.</given-names></name> <name><surname>Horsman</surname> <given-names>S. R.</given-names></name> <name><surname>Charron-Mazenod</surname> <given-names>L.</given-names></name> <name><surname>Turnbull</surname> <given-names>A. L.</given-names></name> <name><surname>Mulcahy</surname> <given-names>H.</given-names></name> <name><surname>Surette</surname> <given-names>M. G.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium</article-title>. <source>BMC Microbiol.</source> <volume>13</volume>:<fpage>115</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2180-13-115</pub-id><pub-id pub-id-type="pmid">23705831</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>L.</given-names></name> <name><surname>Mulcahy</surname> <given-names>H.</given-names></name> <name><surname>Kanevets</surname> <given-names>U.</given-names></name> <name><surname>Shi</surname> <given-names>Y.</given-names></name> <name><surname>Lewenza</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Surface-localized spermidine protects the <italic>Pseudomonas aeruginosa</italic>: outer membrane from antibiotic treatment and oxidative stress</article-title>. <source>J. Bacteriol.</source> <volume>194</volume>, <fpage>813</fpage>&#x02013;<lpage>826</lpage>. <pub-id pub-id-type="doi">10.1128/JB.05230-11</pub-id><pub-id pub-id-type="pmid">22155771</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Juneau</surname> <given-names>R. A.</given-names></name> <name><surname>Pang</surname> <given-names>B.</given-names></name> <name><surname>Weimer</surname> <given-names>K. W. D.</given-names></name> <name><surname>Armbruster</surname> <given-names>C. E.</given-names></name> <name><surname>Swords</surname> <given-names>W. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Nontypeable <italic>Haemophilus influenzae</italic> initiates formation of neutrophil extracellular traps</article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>431</fpage>&#x02013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00660-10</pub-id><pub-id pub-id-type="pmid">20956567</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirchner</surname> <given-names>K. K.</given-names></name> <name><surname>Wagener</surname> <given-names>J. S.</given-names></name> <name><surname>Khan</surname> <given-names>T. Z.</given-names></name> <name><surname>Copenhaver</surname> <given-names>S. C.</given-names></name> <name><surname>Accurso</surname> <given-names>F. J.</given-names></name></person-group> (<year>1996</year>). <article-title>Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>154</volume>, <fpage>1426</fpage>&#x02013;<lpage>1429</lpage>. <pub-id pub-id-type="doi">10.1164/ajrccm.154.5.8912759</pub-id><pub-id pub-id-type="pmid">8912759</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klebanoff</surname> <given-names>S. J.</given-names></name> <name><surname>Kinsella</surname> <given-names>M. G.</given-names></name> <name><surname>Wightt</surname> <given-names>T. N.</given-names></name></person-group> (<year>1993</year>). <article-title>Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H202-chloride system</article-title>. <source>Am. J. Pathol.</source> <volume>143</volume>, <fpage>907</fpage>&#x02013;<lpage>917</lpage>. <pub-id pub-id-type="pmid">8395774</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolaczkowska</surname> <given-names>E.</given-names></name> <name><surname>Kubes</surname> <given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Neutrophil recruitment and function in health and inflammation</article-title>. <source>Nat. Rev. Immunol.</source> <volume>13</volume>, <fpage>159</fpage>&#x02013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/nri3399</pub-id><pub-id pub-id-type="pmid">23435331</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leshner</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Lewis</surname> <given-names>C.</given-names></name> <name><surname>Zheng</surname> <given-names>H.</given-names></name> <name><surname>Chen</surname> <given-names>X. A.</given-names></name> <name><surname>Santy</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures</article-title>. <source>Front. Immunol.</source> <volume>3</volume>:<fpage>307</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2012.00307</pub-id><pub-id pub-id-type="pmid">23060885</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>LiPuma</surname> <given-names>J. J.</given-names></name></person-group> (<year>2010</year>). <article-title>The changing microbial epidemiology in cystic fibrosis</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>23</volume>, <fpage>299</fpage>&#x02013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00068-09</pub-id><pub-id pub-id-type="pmid">20375354</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>T.</given-names></name> <name><surname>Kobayashi</surname> <given-names>S. D.</given-names></name> <name><surname>Quinn</surname> <given-names>M. T.</given-names></name> <name><surname>DeLeo</surname> <given-names>F. R.</given-names></name></person-group> (<year>2012</year>). <article-title>A NET outcome</article-title>. <source>Front. Immunol.</source> <volume>3</volume>:<fpage>365</fpage> <pub-id pub-id-type="doi">10.3389/fimmu.2012.00365</pub-id><pub-id pub-id-type="pmid">23227026</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manzenreiter</surname> <given-names>R.</given-names></name> <name><surname>Kienberger</surname> <given-names>F.</given-names></name> <name><surname>Marcos</surname> <given-names>V.</given-names></name> <name><surname>Schilcher</surname> <given-names>K.</given-names></name> <name><surname>Krautgartner</surname> <given-names>W. D.</given-names></name> <name><surname>Obermayer</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy</article-title>. <source>J. Cystic Fibros.</source> <volume>11</volume>, <fpage>84</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcf.2011.09.008</pub-id><pub-id pub-id-type="pmid">21996135</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marcos</surname> <given-names>V.</given-names></name> <name><surname>Zhou-Suckow</surname> <given-names>Z.</given-names></name> <name><surname>&#x000D6;nder Yildirim</surname> <given-names>A.</given-names></name> <name><surname>Bohla</surname> <given-names>A.</given-names></name> <name><surname>Hector</surname> <given-names>A.</given-names></name> <name><surname>Vitkov</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction</article-title>. <source>Mediators Inflamm.</source> <volume>2015</volume>:<fpage>408935</fpage>. <pub-id pub-id-type="doi">10.1155/2015/408935</pub-id><pub-id pub-id-type="pmid">25918476</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname> <given-names>A.</given-names></name> <name><surname>Heesemann</surname> <given-names>L.</given-names></name> <name><surname>Wagener</surname> <given-names>J.</given-names></name> <name><surname>Marcos</surname> <given-names>V.</given-names></name> <name><surname>Hartl</surname> <given-names>D.</given-names></name> <name><surname>Loeffler</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>NETs formed by human neutrophils inhibit growth of the pathogenic mold Aspergillus fumigatus</article-title>. <source>Microb. Infect.</source> <volume>12</volume>, <fpage>928</fpage>&#x02013;<lpage>936</lpage>. <pub-id pub-id-type="doi">10.1016/j.micinf.2010.06.009</pub-id><pub-id pub-id-type="pmid">20603224</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Menestrina</surname> <given-names>G.</given-names></name> <name><surname>Dalla Serra</surname> <given-names>M.</given-names></name> <name><surname>Comai</surname> <given-names>M.</given-names></name> <name><surname>Coraiola</surname> <given-names>M.</given-names></name> <name><surname>Viero</surname> <given-names>G.</given-names></name> <name><surname>Werner</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2003</year>). <article-title>Ion channels and bacterial infection: the case of &#x003B2;-barrel pore-forming protein toxins of <italic>Staphylococcus aureus</italic></article-title>. <source>FEBS Lett.</source> <volume>552</volume>, <fpage>54</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(03)00850-0</pub-id><pub-id pub-id-type="pmid">12972152</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulcahy</surname> <given-names>H.</given-names></name> <name><surname>Charron-Mazenod</surname> <given-names>L.</given-names></name> <name><surname>Lewenza</surname> <given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Extracellular DNA chelates cations and induces antibiotic resistance in <italic>Pseudomonas aeruginosa</italic> biofilms</article-title>. <source>PLoS Pathog.</source> <volume>4</volume>:<fpage>e1000213</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000213</pub-id><pub-id pub-id-type="pmid">19023416</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neeli</surname> <given-names>I.</given-names></name> <name><surname>Khan</surname> <given-names>S. N.</given-names></name> <name><surname>Radic</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Histone deimination as a response to inflammatory stimuli in neutrophils</article-title>. <source>J. Immunol.</source> <volume>180</volume>, <fpage>1895</fpage>&#x02013;<lpage>1902</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.180.3.1895</pub-id><pub-id pub-id-type="pmid">18209087</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Sullivan</surname> <given-names>B. P.</given-names></name> <name><surname>Freedman</surname> <given-names>S. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Cystic fibrosis</article-title>. <source>Lancet</source> <volume>373</volume>, <fpage>1891</fpage>&#x02013;<lpage>1904</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(09)60327-5</pub-id><pub-id pub-id-type="pmid">19403164</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Painter</surname> <given-names>R. G.</given-names></name> <name><surname>Bonvillain</surname> <given-names>R. W.</given-names></name> <name><surname>Valentine</surname> <given-names>V. G.</given-names></name> <name><surname>Lombard</surname> <given-names>G. A.</given-names></name> <name><surname>LaPlace</surname> <given-names>S. G.</given-names></name> <name><surname>Nauseef</surname> <given-names>W. M.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>The role of chloride anion and CFTR in killing of <italic>Pseudomonas aeruginosa</italic> by normal and CF neutrophils</article-title>. <source>J. Leukoc. Biol.</source> <volume>83</volume>, <fpage>1345</fpage>&#x02013;<lpage>1353</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0907658</pub-id><pub-id pub-id-type="pmid">18353929</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papayannopoulos</surname> <given-names>V.</given-names></name> <name><surname>Metzler</surname> <given-names>K. D.</given-names></name> <name><surname>Hakkim</surname> <given-names>A.</given-names></name> <name><surname>Zychlinsky</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps</article-title>. <source>J. Cell Biol.</source> <volume>191</volume>, <fpage>677</fpage>&#x02013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201006052</pub-id><pub-id pub-id-type="pmid">20974816</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papayannopoulos</surname> <given-names>V.</given-names></name> <name><surname>Staab</surname> <given-names>D.</given-names></name> <name><surname>Zychlinsky</surname> <given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving dnase therapy</article-title>. <source>PLoS ONE</source> <volume>6</volume>:<fpage>e28526</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028526</pub-id><pub-id pub-id-type="pmid">22174830</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Papayannopoulos</surname> <given-names>V.</given-names></name> <name><surname>Zychlinsky</surname> <given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>NETs: a new strategy for using old weapons</article-title>. <source>Trends Immunol.</source> <volume>30</volume>, <fpage>513</fpage>&#x02013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2009.07.011</pub-id><pub-id pub-id-type="pmid">19699684</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pilsczek</surname> <given-names>F. H.</given-names></name> <name><surname>Salina</surname> <given-names>D.</given-names></name> <name><surname>Poon</surname> <given-names>K. K.</given-names></name> <name><surname>Fahey</surname> <given-names>C.</given-names></name> <name><surname>Yipp</surname> <given-names>B. G.</given-names></name> <name><surname>Sibley</surname> <given-names>C. D.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to <italic>Staphylococcus aureus</italic></article-title>. <source>J. Immunol.</source> <volume>185</volume>, <fpage>7413</fpage>&#x02013;<lpage>7425</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1000675</pub-id><pub-id pub-id-type="pmid">21098229</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname> <given-names>S.</given-names></name> <name><surname>Gadjeva</surname> <given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Does NETosis contribute to the bacterial pathoadaptation in cystic fibrosis?</article-title> <source>Front. Immunol.</source> <volume>5</volume>:<fpage>378</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2014.00378</pub-id><pub-id pub-id-type="pmid">25157250</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ratjen</surname> <given-names>F.</given-names></name> <name><surname>Paul</surname> <given-names>K.</given-names></name> <name><surname>van Koningsbruggen</surname> <given-names>S.</given-names></name> <name><surname>Breitenstein</surname> <given-names>S.</given-names></name> <name><surname>Rietschel</surname> <given-names>E.</given-names></name> <name><surname>Nikolaizik</surname> <given-names>W.</given-names></name></person-group> (<year>2005</year>). <article-title>DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha</article-title>. <source>Pediatr. Pulmonol.</source> <volume>39</volume>, <fpage>1</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/ppul.20134</pub-id><pub-id pub-id-type="pmid">15532079</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rochael</surname> <given-names>N. C.</given-names></name> <name><surname>Guimar&#x000E3;es-Costa</surname> <given-names>A. B.</given-names></name> <name><surname>Nascimento</surname> <given-names>M. T. C.</given-names></name> <name><surname>DeSouza-Vieira</surname> <given-names>T. S.</given-names></name> <name><surname>Oliveira</surname> <given-names>M. P.</given-names></name> <name><surname>Garcia e Souza</surname> <given-names>L. F.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Classical ROS-dependent and early/rapid ROS-independent release of Neutrophil Extracellular Traps triggered by Leishmania parasites</article-title>. <source>Sci. Rep.</source> <volume>5</volume>:<fpage>18302</fpage>. <pub-id pub-id-type="doi">10.1038/srep18302</pub-id><pub-id pub-id-type="pmid">26673780</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rogan</surname> <given-names>M. P.</given-names></name> <name><surname>Taggart</surname> <given-names>C. C.</given-names></name> <name><surname>Greene</surname> <given-names>C. M.</given-names></name> <name><surname>Murphy</surname> <given-names>P. G.</given-names></name> <name><surname>O&#x00027;Neill</surname> <given-names>S. J.</given-names></name> <name><surname>McElvaney</surname> <given-names>N. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis</article-title>. <source>J. Infect. Dis.</source> <volume>190</volume>, <fpage>1245</fpage>&#x02013;<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1086/423821</pub-id><pub-id pub-id-type="pmid">15346334</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowe</surname> <given-names>S. M.</given-names></name> <name><surname>Miller</surname> <given-names>S.</given-names></name> <name><surname>Sorscher</surname> <given-names>E. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Cystic fibrosis</article-title>. <source>N. Engl. J. Med.</source> <volume>352</volume>, <fpage>1992</fpage>&#x02013;<lpage>2001</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra043184</pub-id><pub-id pub-id-type="pmid">15888700</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saffarzadeh</surname> <given-names>M.</given-names></name> <name><surname>Juenemann</surname> <given-names>C.</given-names></name> <name><surname>Queisser</surname> <given-names>M. A.</given-names></name> <name><surname>Lochnit</surname> <given-names>G.</given-names></name> <name><surname>Barreto</surname> <given-names>G.</given-names></name> <name><surname>Galuska</surname> <given-names>S. P.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones</article-title>. <source>PLoS ONE</source> <volume>7</volume>:<fpage>e32366</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0032366</pub-id><pub-id pub-id-type="pmid">22389696</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sagel</surname> <given-names>S. D.</given-names></name> <name><surname>Sontag</surname> <given-names>M. K.</given-names></name> <name><surname>Accurso</surname> <given-names>F. J.</given-names></name> <name><surname>Bergsson</surname> <given-names>G.</given-names></name> <name><surname>Reeves</surname> <given-names>E. P.</given-names></name> <name><surname>McNally</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis</article-title>. <source>Pediatr. Pulmonol.</source> <volume>44</volume>, <fpage>402</fpage>&#x02013;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1002/ppul.21028</pub-id><pub-id pub-id-type="pmid">19283840</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saiman</surname> <given-names>L.</given-names></name> <name><surname>Cacalano</surname> <given-names>G.</given-names></name> <name><surname>Prince</surname> <given-names>A.</given-names></name></person-group> (<year>1990</year>). <article-title>Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Infect. Immun.</source> <volume>58</volume>, <fpage>2578</fpage>&#x02013;<lpage>2584</lpage>. <pub-id pub-id-type="pmid">1983811</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sohnle</surname> <given-names>P. G.</given-names></name> <name><surname>Hahn</surname> <given-names>B. L.</given-names></name> <name><surname>Santhanagopalan</surname> <given-names>V.</given-names></name></person-group> (<year>1996</year>). <article-title>Inhibition of <italic>Candida albicans</italic> growth by calprotectin in the absence of direct contact with the organisms</article-title>. <source>J. Infect. Dis.</source> <volume>174</volume>, <fpage>1369</fpage>&#x02013;<lpage>1372</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/174.6.1369</pub-id><pub-id pub-id-type="pmid">8940237</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thammavongsa</surname> <given-names>V.</given-names></name> <name><surname>Missiakas</surname> <given-names>D.</given-names></name> <name><surname>Schneewind</surname> <given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Staphylococcus aureus</italic> degrades neutrophil extracellular traps to promote immune cell death</article-title>. <source>Science</source> <volume>342</volume>, <fpage>863</fpage>&#x02013;<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1126/science.1242255</pub-id><pub-id pub-id-type="pmid">24233725</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname> <given-names>C. F.</given-names></name> <name><surname>Ermert</surname> <given-names>D.</given-names></name> <name><surname>Schmid</surname> <given-names>M.</given-names></name> <name><surname>Abu-Abed</surname> <given-names>U.</given-names></name> <name><surname>Goosmann</surname> <given-names>C.</given-names></name> <name><surname>Nacken</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against <italic>Candida albicans</italic></article-title>. <source>PLoS Pathog.</source> <volume>5</volume>:<fpage>e1000639</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000639</pub-id><pub-id pub-id-type="pmid">19876394</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname> <given-names>C. F.</given-names></name> <name><surname>Reichard</surname> <given-names>U.</given-names></name> <name><surname>Brinkmann</surname> <given-names>V.</given-names></name> <name><surname>Zychlinsky</surname> <given-names>A.</given-names></name></person-group> (<year>2006</year>). <article-title>Neutrophil extracellular traps capture and kill <italic>Candida albicans</italic> and hyphal forms</article-title>. <source>Cell. Microbiol.</source> <volume>8</volume>, <fpage>668</fpage>&#x02013;<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1111/j.1462-5822.2005.00659.x</pub-id><pub-id pub-id-type="pmid">16548892</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voyich</surname> <given-names>J. M.</given-names></name> <name><surname>Braughton</surname> <given-names>K. R.</given-names></name> <name><surname>Sturdevant</surname> <given-names>D. E.</given-names></name> <name><surname>Whitney</surname> <given-names>A. R.</given-names></name> <name><surname>Sa&#x000EF;d-Salim</surname> <given-names>B.</given-names></name> <name><surname>Porcella</surname> <given-names>S. F.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Insights into mechanisms used by <italic>Staphylococcus aureus</italic> to avoid destruction by human neutrophils</article-title>. <source>J. Immunol.</source> <volume>175</volume>, <fpage>3907</fpage>&#x02013;<lpage>3919</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.6.3907</pub-id><pub-id pub-id-type="pmid">16148137</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wakeman</surname> <given-names>C. A.</given-names></name> <name><surname>Moore</surname> <given-names>J. L.</given-names></name> <name><surname>Noto</surname> <given-names>M. J.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Singleton</surname> <given-names>M. D.</given-names></name> <name><surname>Prentice</surname> <given-names>B. M.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>The innate immune protein calprotectin promotes <italic>Pseudomonas aeruginosa</italic> and <italic>Staphylococcus aureus</italic> interaction</article-title>. <source>Nat. Commun.</source> <volume>7</volume>:<fpage>11951</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms11951</pub-id><pub-id pub-id-type="pmid">27301800</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Stadler</surname> <given-names>S.</given-names></name> <name><surname>Correll</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>P.</given-names></name> <name><surname>Wang</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title>Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation</article-title>. <source>J. Cell Biol.</source> <volume>184</volume>, <fpage>205</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200806072</pub-id><pub-id pub-id-type="pmid">19153223</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Welsh</surname> <given-names>M. J.</given-names></name> <name><surname>Smith</surname> <given-names>A. E.</given-names></name></person-group> (<year>1993</year>). <article-title>Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis</article-title>. <source>Cell</source> <volume>73</volume>, <fpage>1251</fpage>&#x02013;<lpage>1254</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(93)90353-R</pub-id><pub-id pub-id-type="pmid">7686820</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winstanley</surname> <given-names>C.</given-names></name> <name><surname>O&#x00027;Brien</surname> <given-names>S.</given-names></name> <name><surname>Brockhurst</surname> <given-names>M. A.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Pseudomonas aeruginosa</italic> evolutionary adaptation and diversification in cystic fibrosis chronic lung infections</article-title>. <source>Trends Microbiol.</source> <volume>24</volume>, <fpage>327</fpage>&#x02013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2016.01.008</pub-id><pub-id pub-id-type="pmid">26946977</pub-id></citation></ref>
<ref id="B65">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yipp</surname> <given-names>B. G.</given-names></name> <name><surname>Kubes</surname> <given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Review Article NETosis : how vital is it ?</article-title> <source>Blood</source> <volume>122</volume>, <fpage>2784</fpage>&#x02013;<lpage>2795</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2013-04-457671</pub-id><pub-id pub-id-type="pmid">24009232</pub-id></citation></ref>
<ref id="B66">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>R. L.</given-names></name> <name><surname>Malcolm</surname> <given-names>K. C.</given-names></name> <name><surname>Kret</surname> <given-names>J. E.</given-names></name> <name><surname>Caceres</surname> <given-names>S. M.</given-names></name> <name><surname>Poch</surname> <given-names>K. R.</given-names></name> <name><surname>Nichols</surname> <given-names>D. P.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Neutrophil extracellular trap (NET)-mediated killing of <italic>Pseudomonas aeruginosa</italic>: evidence of acquired resistance within the CF airway, independent of CFTR</article-title>. <source>PLoS ONE</source> <volume>6</volume>:<fpage>e23637</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0023637</pub-id><pub-id pub-id-type="pmid">21909403</pub-id></citation></ref>
<ref id="B67">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zawrotniak</surname> <given-names>M.</given-names></name> <name><surname>Rapala-Kozik</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Neutrophil extracellular traps (NETs) - formation and implications</article-title>. <source>Acta Biochim. Pol.</source> <volume>60</volume>, <fpage>277</fpage>&#x02013;<lpage>284</lpage>. <pub-id pub-id-type="pmid">23819131</pub-id></citation></ref>
<ref id="B68">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zemanick</surname> <given-names>E. T.</given-names></name> <name><surname>Sagel</surname> <given-names>S. D.</given-names></name> <name><surname>Harris</surname> <given-names>J. K.</given-names></name></person-group> (<year>2011</year>). <article-title>The airway microbiome in cystic fibrosis and implications for treatment</article-title>. <source>Curr. Opin. Pediatr.</source> <volume>23</volume>, <fpage>319</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1097/MOP.0b013e32834604f2</pub-id><pub-id pub-id-type="pmid">21494150</pub-id></citation></ref>
</ref-list>
</back>
</article>